Edwards Lifesciences Corp

NYSE:EW  
78.05
-0.75 (-0.95%)
7:59:52 PM EDT: $78.44 +0.39 (+0.50%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)45.35B
Current PE31.61
Forward PE 31.6
2yr Forward PE 28.28
See more stats
Estimates Current Quarter
Revenue$1.49 Billion
Adjusted EPS$0.62
See more estimates
10-Day MA$77.31
50-Day MA$76.31
200-Day MA$72.05
See more pivots

Edwards Lifesciences Corp Stock, NYSE:EW

1 Edwards Way, Irvine, California 92614
United States of America
Phone: +1.949.250.2500
Number of Employees: 15800

Description

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.